Early stent thrombosis and mortality after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction

George D. Dangas, Mikkel M. Schoos, Philippe Gabriel Steg, Roxana Mehran, Peter Clemmensen, Arnoud Van't Hof, Jayne Prats, Debra Bernstein, Efthymios N. Deliargyris, Gregg W. Stone

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Background - Early stent thrombosis (ST) within 30 days after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction is a serious event. We sought to determine the predictors of and risk of mortality after early ST according to procedural antithrombotic therapy. Methods and Results - In a patient-level pooled analysis from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) and European Ambulance Acute Coronary Syndrome Angiography (EUROMAX) trials, we examined 30-day outcomes in 4935 patients undergoing primary percutaneous coronary intervention with stent implantation at 188 international sites, randomized to either bivalirudin or heparin±a glycoprotein IIb/IIIa inhibitor (GPI). Early ST occurred in 100 patients (2.0%), 20 of whom (20.0%) died. Bivalirudin was associated with higher rates of early ST compared with heparin±GPI (2.5% versus 1.6%, P=0.04), because of more acute (≤24 h) ST (1.5% versus 0.2%, P<0.0001), with the risk limited to the first 4 hours after percutaneous coronary intervention. The rates of subacute (1-30 days) ST were similar with bivalirudin and heparin±GPI (1.0% versus 1.4%, P=0.24). Among patients with early ST, mortality within 30 days occurred in 4 of 60 (6.7%) bivalirudin-treated patients compared with 16 of 40 (40.0%) heparin±GPI-treated patients (adjusted hazard ratio, 0.12; 95% CI, 0.04-0.39; P=0.0004 and adjusted hazard ratio, 0.122; 95% CI, 0.04-0.39; P=0. 0004). Thus, 30-day mortality attributable to early ST occurred in 4 of 2479 (0.2%) bivalirudin-treated patients versus 16 of 2456 (0.7%) heparin±GPI-treated patients (P=0.007). Conclusions - In the present large-scale pooled analysis from 2 multicenter randomized trials, early ST was more frequent in patients treated with bivalirudin compared with heparin±GPI because of increased ST within 4 hours after primary percutaneous coronary intervention. However, the mortality attributable to early ST was significantly lower after bivalirudin than after heparin±GPI.

Original languageEnglish
Article numbere003272
JournalCirculation: Cardiovascular Interventions
Volume9
Issue number5
DOIs
StatePublished - 1 May 2016

Keywords

  • mortality
  • myocardial infarction
  • pharmacology
  • stent
  • thrombosis

Fingerprint

Dive into the research topics of 'Early stent thrombosis and mortality after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction'. Together they form a unique fingerprint.

Cite this